Skip to main navigation Skip to search Skip to main content

Real world use of emicizumab in infants and children ages 0-3 years with hemophilia A

Project: Research

Project Details

StatusActive
Effective start/end date12/6/23 → 12/5/26

Funding

  • Genentech Incorporated: $3,640.00